• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OSL

ONCOSIL MEDICAL LTD - Announcements

1.80% ! $1.09
Market Cap $20.51M  !

OncoSil Medical Ltd is an Australia-based medical device company focused on localized... OncoSil Medical Ltd is an Australia-based medical device company focused on localized treatments for patients with unresectable locally advanced pancreatic cancer (LAPC). The Company is focused on the development and commercialization of its lead product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The Company has developed a cancer treatment device, the OncoSil brachytherapy device, which is a critical component of a brachytherapy treatment for locally advanced unresectable pancreatic cancer. The OncoSil device delivers a targeted intratumoral placement of Phosphorous-32 (32P) in the treatment of locally advanced unresectable pancreatic cancer. The OncoSil device has received a device designation in the European Union, United Kingdom and United States for the treatment of locally advanced unresectable pancreatic cancer in combination with chemotherapy.More

Announcements



OSL Otto Buttula retires and Douglas Cubbin appointed Chair31/08/23 download Created with Sketch. 252.71KB
OSL Appendix 4G31/08/23 download Created with Sketch. 263.76KB
OSL Corporate Governance Statement31/08/23 download Created with Sketch. 163.84KB
OSL Appendix 4E and Annual ReportPRICE SENSITIVE31/08/23 download Created with Sketch. 2.22MB
OSL Change of principal place of business16/08/23 download Created with Sketch. 170.64KB
OSL Initial Director's Interest Notice10/08/23 download Created with Sketch. 201.51KB
OSL Douglas Cubbin appointed as Incoming Chairman of OncoSil07/08/23 download Created with Sketch. 261.42KB
OSL Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/07/23 download Created with Sketch. 356.23KB
OSL Initial Director's Interest Notice GL18/07/23 download Created with Sketch. 202.27KB
OSL Gabriel Liberatore appointed to the Board of OncoSil14/07/23 download Created with Sketch. 171.34KB
OSL Change of Directors Interest Notice - Appendix 3Y OB04/07/23 download Created with Sketch. 229.99KB
OSL Multi-Centre Data on OncoSil in Metastatic Pancreatic CancerPRICE SENSITIVE30/06/23 download Created with Sketch. 226.69KB
OSL Notification of cessation of securities - OSL29/06/23 download Created with Sketch. 23.85KB
OSL Ethics Committee Approves PANCOSIL Clinical TrialPRICE SENSITIVE05/06/23 download Created with Sketch. 199.29KB
OSL Change of CFO, Company Secretary and Registered Office01/06/23 download Created with Sketch. 204.58KB
OSL Resignation of Chief Financial Officer24/05/23 download Created with Sketch. 201.99KB
OSL Mr Otto Buttula to Retire from the Board24/05/23 download Created with Sketch. 389.36KB
OSL First patient treatment in ItalyPRICE SENSITIVE22/05/23 download Created with Sketch. 242.36KB
OSL Becoming a substantial holder12/05/23 download Created with Sketch. 2.38MB
OSL Notification of cessation of securities - OSL12/05/23 download Created with Sketch. 22.26KB
OSL Change of Director's Interest Notice - Brian Leedman11/05/23 download Created with Sketch. 242.5KB
OSL Change of Director's Interest Notice - Nigel Lange11/05/23 download Created with Sketch. 237.66KB
OSL Top 20 Holdings and Distribution Schedule of OSLO Options11/05/23 download Created with Sketch. 728.13KB
OSL Application for quotation of securities - OSL11/05/23 download Created with Sketch. 26.89KB
OSL Entitlement Offer Results and Shortfall Notification09/05/23 download Created with Sketch. 207.54KB
OSL First patient enrolled in the TRIPP-FFX Clinical StudyPRICE SENSITIVE03/05/23 download Created with Sketch. 244.78KB
OSL OncoSil to streamline operating structurePRICE SENSITIVE02/05/23 download Created with Sketch. 212.96KB
OSL First year anniversary of the OSPREY post-marketing registryPRICE SENSITIVE01/05/23 download Created with Sketch. 247.44KB
OSL Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/04/23 download Created with Sketch. 499.43KB
OSL Late Lodgement of Change in Director's Interest Notice24/04/23 download Created with Sketch. 361.15KB
OSL Update - Proposed issue of securities - OSL24/04/23 download Created with Sketch. 33KB
OSL Oral presentation at The Mayo Clinic IMPACT CoursePRICE SENSITIVE24/04/23 download Created with Sketch. 223.77KB
OSL Further commercial milestones achieved in SpainPRICE SENSITIVE24/04/23 download Created with Sketch. 224.69KB
OSL Extension of Closing Date of Entitlement Offer21/04/23 download Created with Sketch. 212KB
OSL Additional Binding Commitment Received for Entitlement OfferPRICE SENSITIVE21/04/23 download Created with Sketch. 209.05KB
OSL Letter to Ineligible Shareholders28/03/23 download Created with Sketch. 272.19KB
OSL Entitlement Offer - Despatch of Documents28/03/23 download Created with Sketch. 206.12KB
OSL Non-renounceable Rights Issue Offer ProspectusPRICE SENSITIVE20/03/23 download Created with Sketch. 819.31KB
OSL Update - Proposed issue of securities - OSL17/03/23 download Created with Sketch. 33KB
OSL Commitment received for Offer and updated TimetablePRICE SENSITIVE17/03/23 download Created with Sketch. 199.79KB
OSL Proposed issue of securities - OSL17/03/23 download Created with Sketch. 33.44KB
OSL Entitlement Offer PresentationPRICE SENSITIVE17/03/23 download Created with Sketch. 982.7KB
OSL Entitlement Offer to raise up to $9.9 millionPRICE SENSITIVE17/03/23 download Created with Sketch. 284.84KB
OSL Final Director's Interest Notice06/03/23 download Created with Sketch. 202.45KB
OSL Change of Director's Interest Notice06/03/23 download Created with Sketch. 234.35KB
OSL Cancellation of Unlisted Options and Loan Funded Shares06/03/23 download Created with Sketch. 211.94KB
OSL Half-Yearly Report ResultsPRICE SENSITIVE28/02/23 download Created with Sketch. 279.79KB
OSL Half Yearly Report and AccountsPRICE SENSITIVE28/02/23 download Created with Sketch. 662.75KB
OSL Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/01/23 download Created with Sketch. 484.51KB
OSL Two key treatment centres treat first patients with OncoSilPRICE SENSITIVE31/01/23 download Created with Sketch. 197.49KB
OSL OncoSil achieves milestone of 10 patients treated in SpainPRICE SENSITIVE15/12/22 download Created with Sketch. 193.65KB
OSL Distribution agreement signed for selected Chinese marketsPRICE SENSITIVE14/12/22 download Created with Sketch. 199.85KB
OSL Change of Director's Interest Notice24/11/22 download Created with Sketch. 239.68KB
OSL Application for quotation of securities - OSL24/11/22 download Created with Sketch. 24.71KB
OSL Cleansing Notice24/11/22 download Created with Sketch. 176.9KB
OSL OncoSil to present at TechKnow Invest 202207/11/22 download Created with Sketch. 195.81KB
OSL Change of Director's Interest Notice07/11/22 download Created with Sketch. 240.01KB
OSL Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE31/10/22 download Created with Sketch. 490.66KB
OSL Change of Registry Address31/10/22 download Created with Sketch. 77.61KB
OSL OncoSil to present at AusBioInvest 202227/10/22 download Created with Sketch. 191.38KB
OSL Change of Director's Interest Notice - Nigel Lange25/10/22 download Created with Sketch. 237.29KB
OSL Notification regarding unquoted securities - OSL25/10/22 download Created with Sketch. 26.65KB
OSL Change of Director's Interest Notice - Brian Leedman25/10/22 download Created with Sketch. 238.21KB
OSL Change of Director's Interest Notice - Ricky Sharma25/10/22 download Created with Sketch. 233.77KB
OSL Change of Director's Interest Notice - Otto Buttula25/10/22 download Created with Sketch. 239.22KB
OSL Notification regarding unquoted securities - OSL25/10/22 download Created with Sketch. 27.53KB
OSL Results of the OncoSil 2022 Annual General Meeting25/10/22 download Created with Sketch. 326.69KB
OSL 2022 AGM CEO PresentationPRICE SENSITIVE25/10/22 download Created with Sketch. 1.08MB
OSL Final Director's Interest Notice24/10/22 download Created with Sketch. 303.31KB
OSL Resignation of Director - Dr Martin Cross24/10/22 download Created with Sketch. 238.07KB
OSL OncoSil Receives $832k R&D Tax IncentivePRICE SENSITIVE24/10/22 download Created with Sketch. 200.03KB
OSL OncoSil to Present at South-West Connect ASX ShowcasePRICE SENSITIVE18/10/22 download Created with Sketch. 1.18MB
OSL Proposed issue of securities - OSL23/09/22 download Created with Sketch. 26.62KB
OSL Notice of Annual General Meeting/Proxy Form23/09/22 download Created with Sketch. 990.75KB
OSL Initial Director's Interest Notice16/09/22 download Created with Sketch. 189.35KB
OSL Brian Leedman appointed to the Board of OncoSil15/09/22 download Created with Sketch. 240.51KB
OSL Appendix 4G and Corporate Governance Statement31/08/22 download Created with Sketch. 631.85KB
OSL Appendix 4E AnnouncementPRICE SENSITIVE31/08/22 download Created with Sketch. 266.82KB
OSL Appendix 4E and Annual ReportPRICE SENSITIVE31/08/22 download Created with Sketch. 2.7MB
OSL Investor PresentationPRICE SENSITIVE03/08/22 download Created with Sketch. 1.04MB
OSL Investor Presentation Webinar Wednesday 3rd August 202201/08/22 download Created with Sketch. 205.49KB
OSL Monthly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE29/07/22 download Created with Sketch. 496.75KB
OSL Patient treated in Spain proceeds to successful resectionPRICE SENSITIVE19/07/22 download Created with Sketch. 213.08KB
OSL Bupa UK Approves Reimbursement for OncoSil in the UKPRICE SENSITIVE04/07/22 download Created with Sketch. 209.93KB
OSL FY 2023 Strategic UpdatePRICE SENSITIVE30/06/22 download Created with Sketch. 217.74KB
OSL OncoSil PanCO Clinical Trial Presented At ESMO World WCGICPRICE SENSITIVE29/06/22 download Created with Sketch. 199.7KB
OSL Application for quotation of securities - OSL14/06/22 download Created with Sketch. 24.77KB
OSL Cleansing Notice14/06/22 download Created with Sketch. 173.19KB
OSL Change of Director's Interest Notice - Otto Buttula14/06/22 download Created with Sketch. 238.17KB
OSL Change of Director's Interest Notice - Nigel Lange14/06/22 download Created with Sketch. 235.78KB
OSL Change of Director's Interest Notice - Martin Cross14/06/22 download Created with Sketch. 233.38KB
OSL Application for quotation of securities - OSL10/06/22 download Created with Sketch. 24.83KB
OSL Entitlement Offer Results and Shortfall NotificationPRICE SENSITIVE09/06/22 download Created with Sketch. 201.99KB
OSL Trading HaltPRICE SENSITIVE08/06/22 download Created with Sketch. 210.38KB
OSL Letter To Ineligible Shareholders10/05/22 download Created with Sketch. 167.32KB
OSL OncoSil Entitlement Offer BookletPRICE SENSITIVE10/05/22 download Created with Sketch. 361.97KB
OSL Application for quotation of securities - OSL09/05/22 download Created with Sketch. 24.88KB
OSL Cleansing Notice09/05/22 download Created with Sketch. 174.12KB
OSL Clarification Of Non-Renouncable Entitlement Offer DetailsPRICE SENSITIVE02/05/22 download Created with Sketch. 846.52KB
OSL Proposed issue of securities - OSL29/04/22 download Created with Sketch. 35.83KB
OSL Otto Buttula retires and Douglas Cubbin appointed Chair
31/08/23 download Created with Sketch. 252.71KB
OSL Appendix 4G
31/08/23 download Created with Sketch. 263.76KB
OSL Corporate Governance Statement
31/08/23 download Created with Sketch. 163.84KB
OSL Appendix 4E and Annual Report
31/08/23PRICE SENSITIVE download Created with Sketch. 2.22MB
OSL Change of principal place of business
16/08/23 download Created with Sketch. 170.64KB
OSL Initial Director's Interest Notice
10/08/23 download Created with Sketch. 201.51KB
OSL Douglas Cubbin appointed as Incoming Chairman of OncoSil
07/08/23 download Created with Sketch. 261.42KB
OSL Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23PRICE SENSITIVE download Created with Sketch. 356.23KB
OSL Initial Director's Interest Notice GL
18/07/23 download Created with Sketch. 202.27KB
OSL Gabriel Liberatore appointed to the Board of OncoSil
14/07/23 download Created with Sketch. 171.34KB
OSL Change of Directors Interest Notice - Appendix 3Y OB
04/07/23 download Created with Sketch. 229.99KB
OSL Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer
30/06/23PRICE SENSITIVE download Created with Sketch. 226.69KB
OSL Notification of cessation of securities - OSL
29/06/23 download Created with Sketch. 23.85KB
OSL Ethics Committee Approves PANCOSIL Clinical Trial
05/06/23PRICE SENSITIVE download Created with Sketch. 199.29KB
OSL Change of CFO, Company Secretary and Registered Office
01/06/23 download Created with Sketch. 204.58KB
OSL Resignation of Chief Financial Officer
24/05/23 download Created with Sketch. 201.99KB
OSL Mr Otto Buttula to Retire from the Board
24/05/23 download Created with Sketch. 389.36KB
OSL First patient treatment in Italy
22/05/23PRICE SENSITIVE download Created with Sketch. 242.36KB
OSL Becoming a substantial holder
12/05/23 download Created with Sketch. 2.38MB
OSL Notification of cessation of securities - OSL
12/05/23 download Created with Sketch. 22.26KB
OSL Change of Director's Interest Notice - Brian Leedman
11/05/23 download Created with Sketch. 242.5KB
OSL Change of Director's Interest Notice - Nigel Lange
11/05/23 download Created with Sketch. 237.66KB
OSL Top 20 Holdings and Distribution Schedule of OSLO Options
11/05/23 download Created with Sketch. 728.13KB
OSL Application for quotation of securities - OSL
11/05/23 download Created with Sketch. 26.89KB
OSL Entitlement Offer Results and Shortfall Notification
09/05/23 download Created with Sketch. 207.54KB
OSL First patient enrolled in the TRIPP-FFX Clinical Study
03/05/23PRICE SENSITIVE download Created with Sketch. 244.78KB
OSL OncoSil to streamline operating structure
02/05/23PRICE SENSITIVE download Created with Sketch. 212.96KB
OSL First year anniversary of the OSPREY post-marketing registry
01/05/23PRICE SENSITIVE download Created with Sketch. 247.44KB
OSL Quarterly Activities/Appendix 4C Cash Flow Report
28/04/23PRICE SENSITIVE download Created with Sketch. 499.43KB
OSL Late Lodgement of Change in Director's Interest Notice
24/04/23 download Created with Sketch. 361.15KB
OSL Update - Proposed issue of securities - OSL
24/04/23 download Created with Sketch. 33KB
OSL Oral presentation at The Mayo Clinic IMPACT Course
24/04/23PRICE SENSITIVE download Created with Sketch. 223.77KB
OSL Further commercial milestones achieved in Spain
24/04/23PRICE SENSITIVE download Created with Sketch. 224.69KB
OSL Extension of Closing Date of Entitlement Offer
21/04/23 download Created with Sketch. 212KB
OSL Additional Binding Commitment Received for Entitlement Offer
21/04/23PRICE SENSITIVE download Created with Sketch. 209.05KB
OSL Letter to Ineligible Shareholders
28/03/23 download Created with Sketch. 272.19KB
OSL Entitlement Offer - Despatch of Documents
28/03/23 download Created with Sketch. 206.12KB
OSL Non-renounceable Rights Issue Offer Prospectus
20/03/23PRICE SENSITIVE download Created with Sketch. 819.31KB
OSL Update - Proposed issue of securities - OSL
17/03/23 download Created with Sketch. 33KB
OSL Commitment received for Offer and updated Timetable
17/03/23PRICE SENSITIVE download Created with Sketch. 199.79KB
OSL Proposed issue of securities - OSL
17/03/23 download Created with Sketch. 33.44KB
OSL Entitlement Offer Presentation
17/03/23PRICE SENSITIVE download Created with Sketch. 982.7KB
OSL Entitlement Offer to raise up to $9.9 million
17/03/23PRICE SENSITIVE download Created with Sketch. 284.84KB
OSL Final Director's Interest Notice
06/03/23 download Created with Sketch. 202.45KB
OSL Change of Director's Interest Notice
06/03/23 download Created with Sketch. 234.35KB
OSL Cancellation of Unlisted Options and Loan Funded Shares
06/03/23 download Created with Sketch. 211.94KB
OSL Half-Yearly Report Results
28/02/23PRICE SENSITIVE download Created with Sketch. 279.79KB
OSL Half Yearly Report and Accounts
28/02/23PRICE SENSITIVE download Created with Sketch. 662.75KB
OSL Quarterly Activities/Appendix 4C Cash Flow Report
31/01/23PRICE SENSITIVE download Created with Sketch. 484.51KB
OSL Two key treatment centres treat first patients with OncoSil
31/01/23PRICE SENSITIVE download Created with Sketch. 197.49KB
OSL OncoSil achieves milestone of 10 patients treated in Spain
15/12/22PRICE SENSITIVE download Created with Sketch. 193.65KB
OSL Distribution agreement signed for selected Chinese markets
14/12/22PRICE SENSITIVE download Created with Sketch. 199.85KB
OSL Change of Director's Interest Notice
24/11/22 download Created with Sketch. 239.68KB
OSL Application for quotation of securities - OSL
24/11/22 download Created with Sketch. 24.71KB
OSL Cleansing Notice
24/11/22 download Created with Sketch. 176.9KB
OSL OncoSil to present at TechKnow Invest 2022
07/11/22 download Created with Sketch. 195.81KB
OSL Change of Director's Interest Notice
07/11/22 download Created with Sketch. 240.01KB
OSL Quarterly Activities/Appendix 4C Cash Flow Report
31/10/22PRICE SENSITIVE download Created with Sketch. 490.66KB
OSL Change of Registry Address
31/10/22 download Created with Sketch. 77.61KB
OSL OncoSil to present at AusBioInvest 2022
27/10/22 download Created with Sketch. 191.38KB
OSL Change of Director's Interest Notice - Nigel Lange
25/10/22 download Created with Sketch. 237.29KB
OSL Notification regarding unquoted securities - OSL
25/10/22 download Created with Sketch. 26.65KB
OSL Change of Director's Interest Notice - Brian Leedman
25/10/22 download Created with Sketch. 238.21KB
OSL Change of Director's Interest Notice - Ricky Sharma
25/10/22 download Created with Sketch. 233.77KB
OSL Change of Director's Interest Notice - Otto Buttula
25/10/22 download Created with Sketch. 239.22KB
OSL Notification regarding unquoted securities - OSL
25/10/22 download Created with Sketch. 27.53KB
OSL Results of the OncoSil 2022 Annual General Meeting
25/10/22 download Created with Sketch. 326.69KB
OSL 2022 AGM CEO Presentation
25/10/22PRICE SENSITIVE download Created with Sketch. 1.08MB
OSL Final Director's Interest Notice
24/10/22 download Created with Sketch. 303.31KB
OSL Resignation of Director - Dr Martin Cross
24/10/22 download Created with Sketch. 238.07KB
OSL OncoSil Receives $832k R&D Tax Incentive
24/10/22PRICE SENSITIVE download Created with Sketch. 200.03KB
OSL OncoSil to Present at South-West Connect ASX Showcase
18/10/22PRICE SENSITIVE download Created with Sketch. 1.18MB
OSL Proposed issue of securities - OSL
23/09/22 download Created with Sketch. 26.62KB
OSL Notice of Annual General Meeting/Proxy Form
23/09/22 download Created with Sketch. 990.75KB
OSL Initial Director's Interest Notice
16/09/22 download Created with Sketch. 189.35KB
OSL Brian Leedman appointed to the Board of OncoSil
15/09/22 download Created with Sketch. 240.51KB
OSL Appendix 4G and Corporate Governance Statement
31/08/22 download Created with Sketch. 631.85KB
OSL Appendix 4E Announcement
31/08/22PRICE SENSITIVE download Created with Sketch. 266.82KB
OSL Appendix 4E and Annual Report
31/08/22PRICE SENSITIVE download Created with Sketch. 2.7MB
OSL Investor Presentation
03/08/22PRICE SENSITIVE download Created with Sketch. 1.04MB
OSL Investor Presentation Webinar Wednesday 3rd August 2022
01/08/22 download Created with Sketch. 205.49KB
OSL Monthly Activities/Appendix 4C Cash Flow Report
29/07/22PRICE SENSITIVE download Created with Sketch. 496.75KB
OSL Patient treated in Spain proceeds to successful resection
19/07/22PRICE SENSITIVE download Created with Sketch. 213.08KB
OSL Bupa UK Approves Reimbursement for OncoSil in the UK
04/07/22PRICE SENSITIVE download Created with Sketch. 209.93KB
OSL FY 2023 Strategic Update
30/06/22PRICE SENSITIVE download Created with Sketch. 217.74KB
OSL OncoSil PanCO Clinical Trial Presented At ESMO World WCGIC
29/06/22PRICE SENSITIVE download Created with Sketch. 199.7KB
OSL Application for quotation of securities - OSL
14/06/22 download Created with Sketch. 24.77KB
OSL Cleansing Notice
14/06/22 download Created with Sketch. 173.19KB
OSL Change of Director's Interest Notice - Otto Buttula
14/06/22 download Created with Sketch. 238.17KB
OSL Change of Director's Interest Notice - Nigel Lange
14/06/22 download Created with Sketch. 235.78KB
OSL Change of Director's Interest Notice - Martin Cross
14/06/22 download Created with Sketch. 233.38KB
OSL Application for quotation of securities - OSL
10/06/22 download Created with Sketch. 24.83KB
OSL Entitlement Offer Results and Shortfall Notification
09/06/22PRICE SENSITIVE download Created with Sketch. 201.99KB
OSL Trading Halt
08/06/22PRICE SENSITIVE download Created with Sketch. 210.38KB
OSL Letter To Ineligible Shareholders
10/05/22 download Created with Sketch. 167.32KB
OSL OncoSil Entitlement Offer Booklet
10/05/22PRICE SENSITIVE download Created with Sketch. 361.97KB
OSL Application for quotation of securities - OSL
09/05/22 download Created with Sketch. 24.88KB
OSL Cleansing Notice
09/05/22 download Created with Sketch. 174.12KB
OSL Clarification Of Non-Renouncable Entitlement Offer Details
02/05/22PRICE SENSITIVE download Created with Sketch. 846.52KB
OSL Proposed issue of securities - OSL
29/04/22 download Created with Sketch. 35.83KB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.09
Change
-0.020(1.80%)
Mkt cap ! $20.51M
Open High Low Value Volume
$1.11 $1.12 $1.08 $19.98K 18.08K

Buyers (Bids)

No. Vol. Price($)
3 3196 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 3598 1
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.